Chembio Diagnostics Stock Price, News & Analysis
Company Description
Chembio Diagnostics (NASDAQ: CEMI) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.
CEMI stock has declined 26.7% over the past year.
This page provides a comprehensive overview of CEMI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Chembio Diagnostics (CEMI) stock. Over the past 12 months, the stock has lost 26.7%.
Latest News
Chembio Diagnostics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition. View all CEMI news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CEMI Company Profile & Sector Positioning
Chembio Diagnostics (CEMI) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.